학술논문

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
Document Type
Article
Source
In Annals of Oncology August 2011 22(8):1812-1823
Subject
Language
ISSN
0923-7534